Trade Summary

2 months ago, Durso Jerome Benedict, serving as Pres, CEO at Altimmune, Inc. (ALT), purchased 20,000 shares at $3.54 per share, for a total transaction value of $70,790.00. Following this transaction, Durso Jerome Benedict now holds 32,500 shares of ALT.

This purchase represents a 160.00% increase in Durso Jerome Benedict's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 9, 2026, 3 days after the trade was made.

Altimmune, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.